Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Cash flows from operating activities:
Net income (loss) attributable to common shareholders	$ (1,973,401)	$ 1,282,103
Adjustments to reconcile net income to net cash used in operating activities:
Amortization (accretion) of investments	84,656	(778,138)
Realized investment gains, net	498,691	(3,412,233)
Unrealized trading (gains) losses included in income	111,531	(14,539)
Realized trading (gains) included in income	(110,470)	0
Amortization of cost of insurance acquired	209,776	218,246
Depreciation	175,471	141,702
Net income (loss) attributable to noncontrolling interest	(141,234)	(94,567)
Charges for mortality and administration of universal life and annuity products	(1,661,871)	(1,107,778)
Interest credited to account balances	1,092,176	867,663
Change in accrued investment income	(191,914)	(112,756)
Change in reinsurance receivables	320,738	17,052
Change in policy liabilities and accruals	3,707	(577,674)
Change in income taxes receivable (payable)	44,380	688,603
Change in other assets and liabilities, net	(1,038,724)	(3,135,372)
Net cash used in operating activities	(2,576,488)	(6,017,688)
Proceeds from investments sold and matured:
Fixed maturities available for sale	2,614,087	6,102,950
Equity securities available for sale	0	438,111
Trading securities	0	0
Mortgage loans	290,019	1,801,132
Real estate	875,507	4,053,937
Notes receivable	99,787	2,499,998
Policy loans	528,338	636,556
Short term investment	0	0
Total proceeds from investments sold and matured	4,407,738	15,532,684
Cost of investments acquired:
Fixed maturities available for sale	(1,977,627)	(3,955,081)
Equity securities available for sale	(2,099,959)	(505,516)
Trading securities	0	0
Mortgage loans	(333,581)	(12,365)
Real estate	(446,391)	(3,526,736)
Notes receivable	(547,853)	0
Policy loans	(351,267)	(565,345)
Short-term investments	0	0
Total cost of investments acquired	(5,756,678)	(8,565,043)
Sale of property and equipment	0	0
Net cash provided by (used in) investing activities	(1,348,940)	6,967,641
Cash flows from financing activities:
Policyholder contract deposits	1,242,214	772,689
Policyholder contract withdrawals	(1,212,530)	(594,960)
Proceeds from notes payable/line of credit	0	0
Payments of principal on notes payable/line of credit	0	0
Purchase of treasury stock	171,203	(403,637)
Non controlling contributions (distributions) of consolidated subsidiary	8,089	(82,265)
Net cash used in financing activities	208,976	(308,173)
Net decrease in cash and cash equivalents	(3,716,452)	641,780
Cash and cash equivalents at beginning of year	15,156,548	11,822,615
Cash and cash equivalents at end of year	$ 11,440,096	$ 12,464,395